 BidaskClub lowered shares of Odonate Therapeutics NASDAQ:ODT from a hold rating to a sell rating in a research report sent to investors on Thursday morning, BidAskClub reports. A number of other analysts have also recently commented on the company. Zacks Investment Research cut Odonate Therapeutics from a buy rating to a hold rating in a ... 